Highly Active Antiretroviral Therapy (HAART)
Enteric Parasitic Infections in HIVAIDS Patients Before and After the Highly Active Antiretroviral Therapy
8
Analysis of HIV- type 1 protease and reverse transcriptase in Brazilian children failing highly active antiretroviral therapy (HAART)
5
Bezafibrate for the treatment of hypertriglyceridemia in HIV1-infected patients on highly active antiretroviral therapy
6
The impact of highly active antiretroviral therapy on the survival of vertically hIV-infected children and adolescents in Belo horizonte, Brazil
7
Effectiveness of highly active antiretroviral therapy using non-brand name drugs in Brazil
5
Prevalence of Hypertension in HIV/AIDS Patients on Highly Active Antiretroviral Therapy (HAART) Compared with HAART-Naive Patients at the Limbe Regional Hospital, Cameroon.
11
Dyslipidemia in AIDS patients on highly active antiretroviral therapy
5
Metabolic Effects Associated to the Highly Active Antiretroviral Therapy (HAART) in AIDS Patients
7
Clinical features and outcomes of AIDS-related cytomegalovirus retinitis in the era of highly active antiretroviral therapy
6
Neurobehavioral effects in HIV-positive individuals receiving highly active antiretroviral therapy (HAART) in Gaborone, Botswana.
7
Recurring Candida albicans Esophagitis in a HIV-Infected Patient Undergoing Long-Term Antiretroviral Therapy, and with Absent-Negligible Immunodeficiency
5
The Influence of HCV Coinfection on Clinical, Immunological and Virological Responses to HAART in HIV-Patients
7
ASYMPTOMATIC ORAL CARRIAGE OF Candida SPECIES IN HIV-INFECTED PATIENTS IN THE HIGHLY ACTIVE ANTIRETROVIRAL THERAPY ERA
5
Seguimento dos doentes soropositivos e soronegativos para o HIV com carcinoma espinocelular do canal anal.
4
Sao Paulo Med. J. vol.125 número5
3
Cad. Saúde Pública vol.23 suppl.3
11
Immune recovery vitritis
3
EFAVIRENZ-INDUCED GYNAECOMASTIA IN HIV INFECTED MALES: A REPORT OF 2 CASES
4
Cardiovascular disease associated with human immunodeficiency virus : a review
13
The evolving landscape of the economics of HIV treatment and prevention.
2